Form 4: CalciMedica Director Boosts Stake with $12,915 Stock Purchase

CalciMedica, Inc. Director Robert N. Wilson acquired 4,500 shares of common stock for $2.87 per share, increasing his direct beneficial ownership to 422,029 shares.

Summary

• Robert N. Wilson, a Director of CalciMedica, Inc. (CALC), purchased 4,500 shares of common stock.
• The transaction occurred on July 18, 2025, at a price of $2.87 per share.
• The total value of the acquisition was $12,915.
• Following this transaction, Mr. Wilson directly beneficially owns 422,029 shares of CalciMedica, Inc. common stock.

Sentiment

Score: 7

Explanation: The insider purchase indicates confidence from a director, which is a positive signal for investors, though the transaction size is relatively small.

Positives

• A Director's purchase of company stock signals confidence in the company's future prospects and valuation.
• The acquisition increases the alignment of management's interests with those of shareholders.

Future Outlook

NA

Industry Context

This transaction reflects an insider's individual investment decision and does not inherently provide broader industry context or trends.

Related Party Transactions

• Director Robert N. Wilson, an insider, purchased 4,500 shares of CalciMedica, Inc. common stock, which is a direct related-party transaction.

Stakeholder Impact

• Shareholders may view the insider purchase as a positive indicator of management's confidence in the company's future, potentially boosting investor sentiment.

Key Dates

Recommendation

Keywords

CalciMedica, CALC, Insider Trading, Stock Purchase, Director, Beneficial Ownership, SEC Form 4, Equity Acquisition